BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cabel L, Proudhon C, Gortais H, Loirat D, Coussy F, Pierga JY, Bidard FC. Circulating tumor cells: clinical validity and utility. Int J Clin Oncol 2017;22:421-30. [PMID: 28238187 DOI: 10.1007/s10147-017-1105-2] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 17.6] [Reference Citation Analysis]
Number Citing Articles
1 Li YR, Tseng CP, Hsu HL, Lin HC, Chen YA, Chen ST, Liou MJ, Lin JD. Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody. Clin Chim Acta 2018;477:74-80. [PMID: 29229463 DOI: 10.1016/j.cca.2017.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
2 Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen EF, Naume B, Wiedswang G. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma. Ann Surg 2020;271:549-58. [PMID: 30216219 DOI: 10.1097/SLA.0000000000003035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
3 Wen YF, Cheng TT, Chen XL, Huang WJ, Peng HH, Zhou TC, Lin XD, Zeng LS. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy. PLoS One 2018;13:e0204334. [PMID: 30303986 DOI: 10.1371/journal.pone.0204334] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
4 Ye Y, Li SL, Wang JJ, Liu B. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14936. [PMID: 30896658 DOI: 10.1097/MD.0000000000014936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Santamaria PG, Moreno-Bueno G, Portillo F, Cano A. EMT: Present and future in clinical oncology. Mol Oncol 2017;11:718-38. [PMID: 28590039 DOI: 10.1002/1878-0261.12091] [Cited by in Crossref: 112] [Cited by in F6Publishing: 122] [Article Influence: 22.4] [Reference Citation Analysis]
6 Liskova A, Samec M, Koklesova L, Giordano FA, Kubatka P, Golubnitschaja O. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management. J Clin Med 2020;9:E2749. [PMID: 32854390 DOI: 10.3390/jcm9092749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Cortés-Hernández LE, Eslami-S Z, Pantel K, Alix-Panabières C. Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application. Clin Chem 2020;66:97-104. [PMID: 31811001 DOI: 10.1373/clinchem.2019.303586] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
8 Pierga JY. Circulating Tumor Cells for Cancer Management. Clin Chem 2019:clinchem. [PMID: 31672852 DOI: 10.1373/clinchem.2019.304766] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Kanayama M, Oyama R, Mori M, Taira A, Shinohara S, Kuwata T, Takenaka M, Yoneda K, Kuroda K, Ohnaga T, Kato Y, Tanaka F. Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma. Oncol Lett 2021;22:522. [PMID: 34025789 DOI: 10.3892/ol.2021.12783] [Reference Citation Analysis]
10 Grüntkemeier L, Khurana A, Bischoff FZ, Hoffmann O, Kimmig R, Moore M, Cotter P, Kasimir-Bauer S. Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™-HER2-FISH workflow. Breast Cancer 2022. [PMID: 35025065 DOI: 10.1007/s12282-022-01330-8] [Reference Citation Analysis]
11 Yoneda K, Kuwata T, Chikaishi Y, Mori M, Kanayama M, Takenaka M, Oka S, Hirai A, Imanishi N, Kuroda K, Ichiki Y, Ohnaga T, Tanaka F. Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma. Cancer Sci 2019;110:726-33. [PMID: 30499156 DOI: 10.1111/cas.13895] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Castro F, Martins C, Silveira MJ, Moura RP, Pereira CL, Sarmento B. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments. Adv Drug Deliv Rev 2021;170:312-39. [PMID: 32946921 DOI: 10.1016/j.addr.2020.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Rau KM, Liu CT, Hsiao YC, Hsiao KY, Wang TM, Hung WS, Su YL, Liu WC, Wang CH, Hsu HL, Chuang PH, Cheng JC, Tseng CP. Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response. J Clin Med. 2020;9. [PMID: 32071283 DOI: 10.3390/jcm9010188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Ravegnini G, Sammarini G, Serrano C, Nannini M, Pantaleo MA, Hrelia P, Angelini S. Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors. Ther Adv Med Oncol 2019;11:1758835919831902. [PMID: 30854029 DOI: 10.1177/1758835919831902] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Keup C, Suryaprakash V, Hauch S, Storbeck M, Hahn P, Sprenger-Haussels M, Kolberg HC, Tewes M, Hoffmann O, Kimmig R, Kasimir-Bauer S. Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer. Genome Med 2021;13:85. [PMID: 34001236 DOI: 10.1186/s13073-021-00902-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gao T, Ding P, Li W, Wang Z, Lin Q, Pei R. Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers. Nanoscale 2020;12:22574-85. [PMID: 33174555 DOI: 10.1039/d0nr06180h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Li Z, Shu J, Yang B, Zhang Z, Huang J, Chen Y. Emerging non-invasive detection methodologies for lung cancer. Oncol Lett 2020;19:3389-99. [PMID: 32269611 DOI: 10.3892/ol.2020.11460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ruiz-Rodríguez AJ, Molina-Vallejo MP, Aznar-Peralta I, González Puga C, Cañas García I, González E, Lorente JA, Serrano MJ, Garrido-Navas MC. Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream). Cancers (Basel) 2021;13:6386. [PMID: 34945008 DOI: 10.3390/cancers13246386] [Reference Citation Analysis]
19 Rasheduzzaman M, Kulasinghe A, Dolcetti R, Kenny L, Johnson NW, Kolarich D, Punyadeera C. Protein glycosylation in head and neck cancers: From diagnosis to treatment. Biochim Biophys Acta Rev Cancer 2020;1874:188422. [PMID: 32853734 DOI: 10.1016/j.bbcan.2020.188422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Singh B, Arora S, D'Souza A, Kale N, Aland G, Bharde A, Quadir M, Calderón M, Chaturvedi P, Khandare J. Chemo-specific designs for the enumeration of circulating tumor cells: advances in liquid biopsy. J Mater Chem B 2021;9:2946-78. [PMID: 33480960 DOI: 10.1039/d0tb02574g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Reduzzi C, Di Cosimo S, Gerratana L, Motta R, Martinetti A, Vingiani A, D'Amico P, Zhang Y, Vismara M, Depretto C, Scaperrotta G, Folli S, Pruneri G, Cristofanilli M, Daidone MG, Cappelletti V. Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer. Cancers (Basel) 2021;13:2356. [PMID: 34068368 DOI: 10.3390/cancers13102356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Galardi F, De Luca F, Biagioni C, Migliaccio I, Curigliano G, Minisini AM, Bonechi M, Moretti E, Risi E, McCartney A, Benelli M, Romagnoli D, Cappadona S, Gabellini S, Guarducci C, Conti V, Biganzoli L, Di Leo A, Malorni L. Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Res 2021;23:38. [PMID: 33761970 DOI: 10.1186/s13058-021-01415-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Maru Y. Premetastasis. Cold Spring Harb Perspect Med 2020;10:a036897. [PMID: 31615874 DOI: 10.1101/cshperspect.a036897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Zhang T, Karsh LI, Nissenblatt MJ, Canfield SE. Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer. Clin Genitourin Cancer 2020;18:1-10. [PMID: 31653572 DOI: 10.1016/j.clgc.2019.09.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
25 Nie Z, Chen M, Gao Y, Huang D, Cao H, Peng Y, Guo N, Zhang S. Regulated Cell Death in Urinary Malignancies. Front Cell Dev Biol 2021;9:789004. [PMID: 34869390 DOI: 10.3389/fcell.2021.789004] [Reference Citation Analysis]
26 Theil G, Fornara P, Bialek J. Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients. Cancers (Basel) 2020;12:E3782. [PMID: 33333999 DOI: 10.3390/cancers12123782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Openshaw MR, McVeigh TP. Non-invasive Technology Advances in Cancer-A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers. Front Digit Health 2020;2:573010. [PMID: 34713045 DOI: 10.3389/fdgth.2020.573010] [Reference Citation Analysis]
28 Zhang Y, Mi X, Tan X, Xiang R. Recent Progress on Liquid Biopsy Analysis using Surface-Enhanced Raman Spectroscopy. Theranostics 2019;9:491-525. [PMID: 30809289 DOI: 10.7150/thno.29875] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
29 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
30 An C, Liu G, Cheng S, Pang B, Sun S, Zhang Y, Pan Z, Kang X. A pilot study of cdc6 as a biomarker for circulating tumor cells in patients with lung cancer. J Clin Lab Anal 2020;34:e23245. [PMID: 32249466 DOI: 10.1002/jcla.23245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Hatzidaki E, Iliopoulos A, Papasotiriou I. A Novel Method for Colorectal Cancer Screening Based on Circulating Tumor Cells and Machine Learning. Entropy (Basel) 2021;23:1248. [PMID: 34681972 DOI: 10.3390/e23101248] [Reference Citation Analysis]
32 Lehmann U, Bartels S. [Liquid biopsy in tumor diagnostics : Applications, perspectives, and limitations of the "cancer liquidome"]. Pathologe 2019;40:250-5. [PMID: 31049676 DOI: 10.1007/s00292-019-0604-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Chudasama D, Bo V, Hall M, Anikin V, Jeyaneethi J, Gregory J, Pados G, Tucker A, Harvey A, Pink R, Karteris E. Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers. Carcinogenesis 2018;39:407-17. [PMID: 29126163 DOI: 10.1093/carcin/bgx122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
34 Reduzzi C, Vismara M, Silvestri M, Celio L, Niger M, Peverelli G, De Braud F, Daidone MG, Cappelletti V. A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.Int J Cancer. 2020;146:3495-3503. [PMID: 31814120 DOI: 10.1002/ijc.32822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
35 Cho H, Kim J, Song H, Sohn KY, Jeon M, Han KH. Microfluidic technologies for circulating tumor cell isolation. Analyst 2018;143:2936-70. [PMID: 29796523 DOI: 10.1039/c7an01979c] [Cited by in Crossref: 70] [Cited by in F6Publishing: 31] [Article Influence: 23.3] [Reference Citation Analysis]
36 Hu X, Zang X, Lv Y. Detection of circulating tumor cells: Advances and critical concerns. Oncol Lett 2021;21:422. [PMID: 33850563 DOI: 10.3892/ol.2021.12683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Gostner JM, Obermayr E, Braicu IE, Concin N, Mahner S, Vanderstichele A, Sehouli J, Vergote I, Fuchs D, Zeillinger R. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium. Gynecol Oncol 2018;149:371-80. [PMID: 29530331 DOI: 10.1016/j.ygyno.2018.02.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Pinzani P, D'Argenio V, Del Re M, Pellegrini C, Cucchiara F, Salvianti F, Galbiati S. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors. Clin Chem Lab Med 2021;59:1181-200. [PMID: 33544478 DOI: 10.1515/cclm-2020-1685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Zhang X, Wang Y, Li Y. [Research Progress of Neutrophil Extracellular Traps in Tumor Metastasis]. Zhongguo Fei Ai Za Zhi 2019;22:600-4. [PMID: 31526465 DOI: 10.3779/j.issn.1009-3419.2019.09.08] [Reference Citation Analysis]
40 Ramzy GM, Koessler T, Ducrey E, McKee T, Ris F, Buchs N, Rubbia-Brandt L, Dietrich PY, Nowak-Sliwinska P. Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma. Cancers (Basel) 2020;12:E1423. [PMID: 32486365 DOI: 10.3390/cancers12061423] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
41 De Rubis G, Rajeev Krishnan S, Bebawy M. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis. Trends Pharmacol Sci. 2019;40:172-186. [PMID: 30736982 DOI: 10.1016/j.tips.2019.01.006] [Cited by in Crossref: 162] [Cited by in F6Publishing: 147] [Article Influence: 54.0] [Reference Citation Analysis]
42 Cortés-Hernández LE, Eslami-S Z, Alix-Panabières C. Liquid Biopsy to Detect Circulating Tumor Cells: Is It Ready for a Value Proposition in Laboratory Medicine? J Appl Lab Med 2020;5:1027-37. [PMID: 32845318 DOI: 10.1093/jalm/jfaa115] [Reference Citation Analysis]
43 Lin J, Ma L, Zhang D, Gao J, Jin Y, Han Z, Lin D. Tumour biomarkers-Tracing the molecular function and clinical implication. Cell Prolif 2019;52:e12589. [PMID: 30873683 DOI: 10.1111/cpr.12589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
44 Burr R, Gilles C, Thompson EW, Maheswaran S. Epithelial-Mesenchymal Plasticity in Circulating Tumor Cells, the Precursors of Metastasis. Adv Exp Med Biol 2020;1220:11-34. [PMID: 32304077 DOI: 10.1007/978-3-030-35805-1_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
45 Jacot W, Cottu P, Berger F, Dubot C, Venat-Bouvet L, Lortholary A, Bourgeois H, Bollet M, Servent V, Luporsi E, Espié M, Guiu S, D'Hondt V, Dieras V, Sablin MP, Brain E, Neffati S, Pierga JY, Bidard FC. Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial. Breast Cancer Res 2019;21:121. [PMID: 31727113 DOI: 10.1186/s13058-019-1215-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
46 Lin Z, Luo G, Du W, Kong T, Liu C, Liu Z. Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor‐On‐A‐Chip. Small 2019;16:1903899. [DOI: 10.1002/smll.201903899] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
47 Tanguy ML, Cabel L, Berger F, Pierga JY, Savignoni A, Bidard FC. Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer. NPJ Breast Cancer 2018;4:14. [PMID: 29951582 DOI: 10.1038/s41523-018-0068-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Miccio L, Cimmino F, Kurelac I, Villone MM, Bianco V, Memmolo P, Merola F, Mugnano M, Capasso M, Iolascon A, Maffettone PL, Ferraro P. Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips. View 2020;1:20200034. [DOI: 10.1002/viw.20200034] [Cited by in Crossref: 17] [Article Influence: 8.5] [Reference Citation Analysis]
49 Bai R, Lv Z, Chen X, Guo H, Bai L, Tian H, Li W, Cui J. Precision Detection Technology: Equipping Precision Oncology with Wings. J Oncol 2020;2020:9068121. [PMID: 32695166 DOI: 10.1155/2020/9068121] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol 2021; 27(43): 7546-7562 [PMID: 34887648 DOI: 10.3748/wjg.v27.i43.7546] [Reference Citation Analysis]
51 Nicolazzo C, Raimondi C, Gradilone A, Emiliani A, Zeuner A, Francescangeli F, Belardinilli F, Seminara P, Loreni F, Magri V, Tomao S, Gazzaniga P. Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer. Cancers (Basel) 2019;11:E1042. [PMID: 31344798 DOI: 10.3390/cancers11081042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
52 IJzerman MJ, de Boer J, Azad A, Degeling K, Geoghegan J, Hewitt C, Hollande F, Lee B, To YH, Tothill RW, Wright G, Tie J, Dawson SJ. Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late. Diagnostics (Basel) 2021;11:103. [PMID: 33440749 DOI: 10.3390/diagnostics11010103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Šamec N, Zottel A, Videtič Paska A, Jovčevska I. Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma. Molecules 2020;25:E490. [PMID: 31979318 DOI: 10.3390/molecules25030490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
54 Chen J, Cao S, Situ B, Zhong J, Hu Y, Li S, Huang J, Xu J, Wu S, Lin J, Zhao Q, Cai Z, Zheng L, Wang Q. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer. J Exp Clin Cancer Res 2018;37:127. [PMID: 29954422 DOI: 10.1186/s13046-018-0789-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
55 Zhang SY, Qin S, Li GH, Yi YQ, Fu HJ, Gao YJ, Sun ML. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance. Hua Xi Kou Qiang Yi Xue Za Zhi 2021;39:591-7. [PMID: 34636209 DOI: 10.7518/hxkq.2021.05.015] [Reference Citation Analysis]
56 Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. The biology and clinical potential of circulating tumor cells. Radiol Oncol 2019;53:131-47. [PMID: 31104002 DOI: 10.2478/raon-2019-0024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
57 Basso U, Facchinetti A, Rossi E, Maruzzo M, Conteduca V, Aieta M, Massari F, Fraccon AP, Mucciarini C, Sava T, Santoni M, Pegoraro C, Durante E, Nicodemo M, Perin A, Bearz A, Gatti C, Fiduccia P, Diminutto A, Barile C, De Giorgi U, Zamarchi R, Zagonel V. Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial. Oncologist 2021;26:740-50. [PMID: 34077597 DOI: 10.1002/onco.13842] [Reference Citation Analysis]
58 Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G. Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer. Cancers (Basel) 2021;13:485. [PMID: 33513877 DOI: 10.3390/cancers13030485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Cantini G, Canu L, Armignacco R, Salvianti F, De Filpo G, Ercolino T, Nesi G, Maggi M, Mannelli M, Pinzani P, Luconi M. Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study. Cancers (Basel) 2020;12:E3176. [PMID: 33138000 DOI: 10.3390/cancers12113176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Deán-Ben XL, Weidenfeld I, Degtyaruk O, Ntziachristos V, Stiel AC, Razansky D. Deep tissue volumetric optoacoustic tracking of individual circulating tumor cells in an intracardially perfused mouse model. Neoplasia 2020;22:441-6. [PMID: 32653834 DOI: 10.1016/j.neo.2020.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Litti L, Colusso A, Pinto M, Ruli E, Scarsi A, Ventura L, Toffoli G, Colombatti M, Fracasso G, Meneghetti M. SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells. Sci Rep 2020;10:15805. [PMID: 32978492 DOI: 10.1038/s41598-020-72911-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Coppola L, Smaldone G, Cianflone A, Baselice S, Mirabelli P, Salvatore M. Purification of viable peripheral blood mononuclear cells for biobanking using a robotized liquid handling workstation. J Transl Med 2019;17:371. [PMID: 31718655 DOI: 10.1186/s12967-019-2125-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
63 Rossi E, Fabbri F. CTCs 2020: Great Expectations or Unreasonable Dreams. Cells 2019;8:E989. [PMID: 31461978 DOI: 10.3390/cells8090989] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
64 Lampignano R, Yang L, Neumann MHD, Franken A, Fehm T, Niederacher D, Neubauer H. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. Int J Mol Sci 2017;18:E1885. [PMID: 28858218 DOI: 10.3390/ijms18091885] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
65 Zhang Y, Zarrabi K, Hou W, Madajewicz S, Choi M, Zucker S, Chen WT. Assessing Clinical Outcomes in Colorectal Cancer with Assays for Invasive Circulating Tumor Cells. Biomedicines 2018;6:E69. [PMID: 29882767 DOI: 10.3390/biomedicines6020069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
66 Li Z, Xu K, Tartarone A, Santarpia M, Zhu Y, Jiang G. Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study. Transl Lung Cancer Res 2021;10:995-1006. [PMID: 33718038 DOI: 10.21037/tlcr-21-149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Gao W, Chen Y, Yang J, Zhuo C, Huang S, Zhang H, Shi Y. Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer. Front Genet 2021;12:634642. [PMID: 33584829 DOI: 10.3389/fgene.2021.634642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Eslami-S Z, Cortés-Hernández LE, Alix-Panabières C. The Metastatic Cascade as the Basis for Liquid Biopsy Development. Front Oncol 2020;10:1055. [PMID: 32850309 DOI: 10.3389/fonc.2020.01055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
69 Shotton R, Lamarca A, Valle J, McNamara MG. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review. World J Gastrointest Oncol 2021; 13(9): 1073-1085 [PMID: 34616513 DOI: 10.4251/wjgo.v13.i9.1073] [Reference Citation Analysis]
70 Fang P, Zhou J, Xia Z, Lu Y, Liu X. Effects of Propofol Versus Sevoflurane on Postoperative Breast Cancer Prognosis: A Narrative Review. Front Oncol 2022;11:793093. [DOI: 10.3389/fonc.2021.793093] [Reference Citation Analysis]
71 Saenz-Antoñanzas A, Auzmendi-Iriarte J, Carrasco-Garcia E, Moreno-Cugnon L, Ruiz I, Villanua J, Egaña L, Otaegui D, Samprón N, Matheu A. Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges. Cancers (Basel) 2019;11:E950. [PMID: 31284524 DOI: 10.3390/cancers11070950] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
72 Zheng W, Zhang Y, Guo L, Wang S, Fang M, Mao W, Lou J. Evaluation of therapeutic efficacy with CytoSorter® circulating tumor cell-capture system in patients with locally advanced head and neck squamous cell carcinoma. Cancer Manag Res 2019;11:5857-69. [PMID: 31303792 DOI: 10.2147/CMAR.S208409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
73 Kampoli K, Foukas PG, Ntavatzikos A, Arkadopoulos N, Koumarianou A. Interrogating the interplay of angiogenesis and immunity in metastatic colorectal cancer. World J Methodol 2022; 12(1): 43-53 [DOI: 10.5662/wjm.v12.i1.43] [Reference Citation Analysis]
74 Ortega MA, Fraile-Martínez O, García-Honduvilla N, Coca S, Álvarez-Mon M, Buján J, Teus MA. Update on uveal melanoma: Translational research from biology to clinical practice (Review). Int J Oncol 2020;57:1262-79. [PMID: 33173970 DOI: 10.3892/ijo.2020.5140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
75 Klusa D, Lohaus F, Furesi G, Rauner M, Benešová M, Krause M, Kurth I, Peitzsch C. Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response. Front Oncol 2020;10:627379. [PMID: 33747899 DOI: 10.3389/fonc.2020.627379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Mansouri S, Mokhtari-Hesari P, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L. The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review. Curr Stem Cell Res Ther 2019;14:519-29. [PMID: 30843493 DOI: 10.2174/1574888X14666190306103759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
77 Wang Z, Ding P, Gao T, Chen C, Cao Y, Sun N, Pei R. Capture of Circulating Tumor Cells by Hydrogel-Nanofiber Substrate. Chinese Journal of Analytical Chemistry 2019;47:1162-9. [DOI: 10.1016/s1872-2040(19)61180-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
78 IJzerman MJ, Berghuis AMS, de Bono JS, Terstappen LWMM. Health economic impact of liquid biopsies in cancer management. Expert Rev Pharmacoecon Outcomes Res 2018;18:593-9. [PMID: 30052095 DOI: 10.1080/14737167.2018.1505505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
79 Kong D, Zhang W, Yang Z, Li G, Cheng S, Zhang K, Feng L. Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis. Oncoimmunology 2021;10:1938476. [PMID: 34211802 DOI: 10.1080/2162402X.2021.1938476] [Reference Citation Analysis]
80 Genna A, Vanwynsberghe AM, Villard AV, Pottier C, Ancel J, Polette M, Gilles C. EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers (Basel) 2020;12:E1632. [PMID: 32575608 DOI: 10.3390/cancers12061632] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
81 Harigopal M, Kowalski D, Vosoughi A. Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer. Expert Rev Mol Diagn 2020;20:815-28. [PMID: 32546017 DOI: 10.1080/14737159.2020.1784009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Liu DG, Xue L, Li J, Yang Q, Peng JZ. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer. Cancer Biomark. 2018;22:417-426. [PMID: 29758927 DOI: 10.3233/CBM-170995] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
83 Maly V, Maly O, Kolostova K, Bobek V. Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer. In Vivo 2019;33:1027-37. [PMID: 31280190 DOI: 10.21873/invivo.11571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
84 Wang J, Koo KM, Wang Y, Trau M. Engineering State-of-the-Art Plasmonic Nanomaterials for SERS-Based Clinical Liquid Biopsy Applications. Adv Sci (Weinh) 2019;6:1900730. [PMID: 31832306 DOI: 10.1002/advs.201900730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
85 Aleotti V, Catoni C, Poggiana C, Rosato A, Facchinetti A, Scaini MC. Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy. Cancers (Basel) 2021;13:6217. [PMID: 34944843 DOI: 10.3390/cancers13246217] [Reference Citation Analysis]
86 Ramani VC, Lemaire CA, Triboulet M, Casey KM, Heirich K, Renier C, Vilches-Moure JG, Gupta R, Razmara AM, Zhang H, Sledge GW, Sollier E, Jeffrey SS. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res 2019;21:98. [PMID: 31462307 DOI: 10.1186/s13058-019-1182-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
87 Cho H, Chung JS, Han KH. A Direct Comparison between the Lateral Magnetophoretic Microseparator and AdnaTest for Isolating Prostate Circulating Tumor Cells. Micromachines (Basel) 2020;11:E870. [PMID: 32961814 DOI: 10.3390/mi11090870] [Reference Citation Analysis]
88 Koulouridi A, Messaritakis I, Theodorakis E, Chondrozoumaki M, Sfakianaki M, Gouvas N, Tsiaoussis J, Mavroudis D, Tzardi M, Souglakos J. Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment. Cancers (Basel) 2021;13:3552. [PMID: 34298766 DOI: 10.3390/cancers13143552] [Reference Citation Analysis]
89 Werner S, Keller L, Pantel K. Epithelial keratins: Biology and implications as diagnostic markers for liquid biopsies. Mol Aspects Med 2020;72:100817. [PMID: 31563278 DOI: 10.1016/j.mam.2019.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
90 Herrero C, Abal M, Muinelo-Romay L. Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges. Front Oncol 2020;10:565666. [PMID: 33178595 DOI: 10.3389/fonc.2020.565666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Iacoangeli A, Adzovic L, Chen EQ, Latif Cattie R, Soff GA, Tiedge H. Regulatory BC200 RNA in peripheral blood of patients with invasive breast cancer. J Investig Med 2018;66:1055-63. [PMID: 29967012 DOI: 10.1136/jim-2018-000717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
92 Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics 2021;13:1879. [PMID: 34834295 DOI: 10.3390/pharmaceutics13111879] [Reference Citation Analysis]
93 Kamińska P, Buszka K, Zabel M, Nowicki M, Alix-Panabières C, Budna-Tukan J. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring. Int J Mol Sci 2021;22:9714. [PMID: 34575876 DOI: 10.3390/ijms22189714] [Reference Citation Analysis]
94 Bian J, Yan K, Liu N, Xu X. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer. J Cancer Res Clin Oncol 2020;146:2621-30. [PMID: 32661602 DOI: 10.1007/s00432-020-03244-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Bittner AK, Keup C, Hoffmann O, Hauch S, Kimmig R, Kasimir-Bauer S. Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patients. J Cell Mol Med 2020;24:8405-16. [PMID: 32558176 DOI: 10.1111/jcmm.15349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Hovaguimian F, Braun J, Z’graggen BR, Schläpfer M, Dumrese C, Ewald C, Dedes KJ, Fink D, Rölli U, Seeberger M, Tausch C, Papassotiropoulos B, Puhan MA, Beck-schimmer B. Anesthesia and Circulating Tumor Cells in Primary Breast Cancer Patients. Anesthesiology 2020;133:548-58. [DOI: 10.1097/aln.0000000000003409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]